Indoco Remedies Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.162x

Indoco Remedies Limited cash flow conversion efficiency. Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.58 Billion ≈ $17.06 Million USD) by net assets (Rs9.74 Billion ≈ $105.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Indoco Remedies Limited (2004–2026)

Cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2026. This chart illustrates how Indoco Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Indoco Remedies Limited stock quote for real-time trading data and today's change.

Indoco Remedies Limited Cash Flow Conversion Ratio Explained

Indoco Remedies Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Indoco Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indoco Remedies Limited ranked by their cash flow conversion efficiency. Also see market cap of Indoco Remedies Limited for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sweeten Real Estate Development Co Ltd TW:5525	-0.067x
Skue Sparebank OL:SKUE	0.056x
TRG Latin America Acquisitions Corp. Class A Ordinary Shares NASDAQ:TRGS	0.000x
Silver Storm Mining Ltd. V:SVRS	-0.085x
SES AI Corp NYSE:SES	-0.097x
Jiangsu Boamax Technologies Group Co Ltd SHE:002514	-0.221x
Celik Halat ve Tel Sanayi AS IS:CELHA	-0.030x
Bakkt Holdings Inc NYSE:BKKT	-0.071x

Annual Cash Flow Conversion Efficiency for Indoco Remedies Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2026. Review Indoco Remedies Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs9.32 Billion ≈ $100.81 Million	Rs324.30 Million ≈ $3.51 Million	0.035x	+27.04%
2025-03-31	Rs10.18 Billion ≈ $110.13 Million	Rs278.90 Million ≈ $3.02 Million	0.027x	-80.43%
2024-03-31	Rs11.10 Billion ≈ $120.10 Million	Rs1.55 Billion ≈ $16.80 Million	0.140x	-19.54%
2023-03-31	Rs10.28 Billion ≈ $111.20 Million	Rs1.79 Billion ≈ $19.34 Million	0.174x	-9.50%
2022-03-31	Rs9.05 Billion ≈ $97.83 Million	Rs1.74 Billion ≈ $18.80 Million	0.192x	+79.71%
2021-03-31	Rs7.69 Billion ≈ $83.16 Million	Rs822.22 Million ≈ $8.89 Million	0.107x	-40.85%
2020-03-31	Rs6.80 Billion ≈ $73.49 Million	Rs1.23 Billion ≈ $13.29 Million	0.181x	-9.61%
2019-03-31	Rs6.61 Billion ≈ $71.44 Million	Rs1.32 Billion ≈ $14.29 Million	0.200x	+10.00%
2018-03-31	Rs6.75 Billion ≈ $73.00 Million	Rs1.23 Billion ≈ $13.27 Million	0.182x	+33.64%
2017-03-31	Rs6.52 Billion ≈ $70.46 Million	Rs886.40 Million ≈ $9.59 Million	0.136x	-29.86%
2016-03-31	Rs5.84 Billion ≈ $63.19 Million	Rs1.13 Billion ≈ $12.26 Million	0.194x	-8.10%
2015-03-31	Rs5.19 Billion ≈ $56.11 Million	Rs1.09 Billion ≈ $11.84 Million	0.211x	-2.30%
2014-03-31	Rs4.57 Billion ≈ $49.47 Million	Rs988.09 Million ≈ $10.69 Million	0.216x	+29.87%
2013-03-31	Rs4.14 Billion ≈ $44.78 Million	Rs688.69 Million ≈ $7.45 Million	0.166x	+8.53%
2012-03-31	Rs3.85 Billion ≈ $41.61 Million	Rs589.71 Million ≈ $6.38 Million	0.153x	+27.38%
2011-03-31	Rs3.50 Billion ≈ $37.87 Million	Rs421.36 Million ≈ $4.56 Million	0.120x	-21.91%
2010-03-31	Rs3.11 Billion ≈ $33.58 Million	Rs478.40 Million ≈ $5.17 Million	0.154x	+13.60%
2009-03-31	Rs2.78 Billion ≈ $30.11 Million	Rs377.64 Million ≈ $4.08 Million	0.136x	+30.76%
2008-03-31	Rs2.54 Billion ≈ $27.50 Million	Rs263.71 Million ≈ $2.85 Million	0.104x	+185.15%
2007-03-31	Rs2.33 Billion ≈ $25.20 Million	Rs84.76 Million ≈ $916.63K	0.036x	-80.49%
2006-03-31	Rs1.98 Billion ≈ $21.45 Million	Rs369.86 Million ≈ $4.00 Million	0.186x	+438.09%
2005-03-31	Rs1.75 Billion ≈ $18.96 Million	Rs60.74 Million ≈ $656.92K	0.035x	-81.85%
2004-03-31	Rs880.11 Million ≈ $9.52 Million	Rs168.02 Million ≈ $1.82 Million	0.191x	--

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic

Market Cap

$207.64 Million

Rs19.20 Billion INR

Market Cap Rank

#16205 Global

#823 in India

Share Price

Rs208.30

Change (1 day)

-0.57%

52-Week Range

Rs164.00 - Rs274.85

All Time High

Rs511.66